{"entity":{"type":"insider","cik":"0001505148","url":"/insider/0001505148","json_url":"/insider/0001505148.json","name":"Lerner Neil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2011-03-21","last":"2026-04-30","span_basis":"filed_date"},"name_variants":[{"name":"Lerner Neil","source":"filing","n_filings":9,"first_seen":"2011-03-21","last_seen":"2026-04-30"}],"transactions":[{"id":9238131,"accession":"0001171843-26-002894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-26-002894","line_url":"/filing/0001171843-26-002894#line-1","is_derivative":false,"issuer_cik":"0001505148","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001505148","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (Chief Accounting Officer)","officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":28350.0,"total_display":"28,350.00","shares_owned_after":397500.0,"shares_owned_after_display":"397,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-29","filed_date":"2026-04-30","scope":"insider"},{"id":4844817,"accession":"0001171843-25-002084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-25-002084","line_url":"/filing/0001171843-25-002084#line-1","is_derivative":false,"issuer_cik":"0001505148","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001505148","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (CHIEF ACCOUNTING OFFICER)","officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":28400.0,"total_display":"28,400.00","shares_owned_after":320000.0,"shares_owned_after_display":"320,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-08","scope":"insider"},{"id":8074009,"accession":"0001373894-19-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373894-19-000015","line_url":"/filing/0001373894-19-000015#line-2","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1412.0,"shares_display":"1,412","price_per_share":15.06,"price_display":"15.06","price_state":"stated","total_value":21264.72,"total_display":"21,264.72","shares_owned_after":13220.0,"shares_owned_after_display":"13,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-13","scope":"insider"},{"id":8074004,"accession":"0001373894-19-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373894-19-000015","line_url":"/filing/0001373894-19-000015#line-1","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7645.0,"shares_display":"7,645","price_per_share":15.11,"price_display":"15.11","price_state":"stated","total_value":115515.95,"total_display":"115,515.95","shares_owned_after":14632.0,"shares_owned_after_display":"14,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-13","scope":"insider"},{"id":6675066,"accession":"0001739481-18-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739481-18-000025","line_url":"/filing/0001739481-18-000025#line-2","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1879.0,"shares_display":"1,879","price_per_share":19.99,"price_display":"19.99","price_state":"stated","total_value":37561.21,"total_display":"37,561.21","shares_owned_after":22277.0,"shares_owned_after_display":"22,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-22","filed_date":"2018-05-23","scope":"insider"},{"id":6675061,"accession":"0001739481-18-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739481-18-000025","line_url":"/filing/0001739481-18-000025#line-1","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3013.0,"shares_display":"3,013","price_per_share":20.14,"price_display":"20.14","price_state":"stated","total_value":60681.82,"total_display":"60,681.82","shares_owned_after":24156.0,"shares_owned_after_display":"24,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-23","scope":"insider"},{"id":3098811,"accession":"0001505148-16-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001505148-16-000005","line_url":"/filing/0001505148-16-000005#line-1","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":24.75,"price_display":"24.75","price_state":"stated","total_value":74250.0,"total_display":"74,250.00","shares_owned_after":25722.0,"shares_owned_after_display":"25,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-21","scope":"insider"},{"id":8857145,"accession":"0001041889-15-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001041889-15-000022","line_url":"/filing/0001041889-15-000022#line-1","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.32,"price_display":"10.32","price_state":"stated","total_value":30960.0,"total_display":"30,960.00","shares_owned_after":30051.0,"shares_owned_after_display":"30,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-14","scope":"insider"},{"id":2828489,"accession":"0001041889-12-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001041889-12-000016","line_url":"/filing/0001041889-12-000016#line-1","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","shares_owned_after":18695.0,"shares_owned_after_display":"18,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-15","filed_date":"2012-06-19","scope":"insider"},{"id":9047719,"accession":"0001505148-11-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001505148-11-000007","line_url":"/filing/0001505148-11-000007#line-2","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (VP - Finance)","officer_title":"VP - Finance","security_title":"Common Stock, $.005 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5895.0,"shares_display":"5,895","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":59008.95,"total_display":"59,008.95","shares_owned_after":12595.0,"shares_owned_after_display":"12,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-25","filed_date":"2011-05-26","scope":"insider"},{"id":9115385,"accession":"0001240679-11-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001240679-11-000017","line_url":"/filing/0001240679-11-000017#line-1","is_derivative":false,"issuer_cik":"0000806517","issuer_name":"PSYCHEMEDICS CORP","issuer_ticker":"PMD","issuer_name_source":null,"issuer_url":"/issuer/0000806517","owner_cik":"0001505148","owner_name":"Lerner Neil","owner_url":"/insider/0001505148","role":"Officer (Vice President and Controller)","officer_title":"Vice President and Controller","security_title":"Common Stock, $.005 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.091,"price_display":"9.09","price_state":"stated","total_value":18182.0,"total_display":"18,182.00","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-17","filed_date":"2011-03-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001738021","name":"Compass Therapeutics, Inc.","url":"/issuer/0001738021","role":"Officer (Chief Accounting Officer)","n_filings":2,"first_seen":"2025-04-08","last_seen":"2026-04-30"},{"type":"issuer","type_label":"ISSUER","cik":"0000806517","name":"PSYCHEMEDICS CORP","url":"/issuer/0000806517","role":"Officer (VP - Finance)","n_filings":7,"first_seen":"2011-03-21","last_seen":"2019-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001505148","retrieved_at":"2026-08-22T04:04:38+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}